Roger M. Perlmutter - Articles and news items

Merck logo

Merck announces presentation of interim data from study evaluating Lambrolizumab

Industry news, News / 2 June 2013 / Merck

Merck expands Lambrolizumab clinical development program…

Amgen logo

Amgen and FDA agree to modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy

Industry news, News / 6 December 2011 / Amgen

FDA has modified the requirements of the Nplate® (romiplostim) REMS Program…

Amgen logo

Amgen submits application to expand indication for XGEVA® (Denosumab)

Industry news, News / 27 June 2011 / Amgen

Amgen announced the submission of a supplemental Biologics License Application to the U.S. FDA to expand the indication for XGEVA® (denosumab)…

Amgen logo

Amgen and UCB announce positive phase 2 results of AMG 785/CDP7851 in Patients With PMO

Industry news, News / 21 April 2011 / Amgen

Amgen & UCB announced positive top-line results from their Phase 2 clinical study…

Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass

Industry news, News / 24 January 2011 / Amgen

Amgen announced that the companies have entered into a definitive acquisition agreement under which Amgen is to acquire BioVex Group…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...